SCHEMBL5709502

SCHEMBL5709502

NC(=O)OC1CCN(CCOc2ccc(Cl)cc2)CC1

nearest known ligand 0.60

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.60
HRH3 Q9Y5N1 6/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KCNA5 P22460 3/20 0.56
DRD3 P35462 2/20 0.54
DRD2 P14416 1/20 0.54
LTA4H P09960 2/20 0.53
PTGS2 P35354 1/20 0.53
MCHR1 Q99705 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28619817 0.94 SIGMAR1 (0.62) SIGMAR1HRH3MEN1KMT2ADRD3
SCHEMBL5709501 0.88 LTA4H (0.55) MEN1KMT2AKCNA5DRD3DRD2
SCHEMBL28619862 0.84 LTA4H (0.70) SIGMAR1HRH3MEN1KMT2AALDH1A1
SCHEMBL5709457 0.84 SIGMAR1 (0.60) SIGMAR1HRH3MEN1KMT2AALDH1A1
SCHEMBL2324373 0.83 MCHR1 (0.80) MCHR1
SCHEMBL28632356 0.81 SIGMAR1 (0.56) SIGMAR1HRH3MEN1KMT2AALDH1A1
SCHEMBL28511016 0.81 DRD4 (0.59) MEN1KMT2ADRD3DRD2
SCHEMBL5723567 0.79 HRH3 (0.76) HRH3
SCHEMBL28513178 0.78 ATF4 (0.59) SIGMAR1HRH3ALDH1A1DRD3DRD2
SCHEMBL5709509 0.77 SIGMAR1 (0.54) SIGMAR1HRH3MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720550-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS Sanofi-Aventis (FR) 2006-11-15 EP disclosed
WO-2005089759-A1 DERIVATIVES OF PIPERIDINYLALKYLCARBAMATES, PREPARATION METHOD THEREOF AND USE OF SAME AS FAAH ENZYME INHIBITORS SANOFI-AVENTIS (FR) 2005-09-29 WO disclosed